Ebru Engin Delipoyraz

ORCID: 0000-0003-4979-3630
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neuroendocrine Tumor Research Advances
  • Lung Cancer Research Studies
  • Neuroblastoma Research and Treatments
  • Lung Cancer Diagnosis and Treatment
  • Melanoma and MAPK Pathways
  • Cutaneous Melanoma Detection and Management
  • Effects of Radiation Exposure
  • Nuclear Physics and Applications
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cancer, Hypoxia, and Metabolism
  • Liver Disease Diagnosis and Treatment
  • Superconducting Materials and Applications
  • Cardiac Structural Anomalies and Repair
  • Occupational and environmental lung diseases
  • Cardiac tumors and thrombi
  • Magnetic confinement fusion research
  • Peptidase Inhibition and Analysis
  • CAR-T cell therapy research

Istanbul Medipol University
2024-2025

Cardiac metastasis is rarely detected in oncology practice. Herein we present a rare case of metastatic gastric cancer that metastasized to the right atrium and presented with heart failure. A 51-year-old male patient no known chronic disease fatigue, abdominal distension leg edema for 3 weeks. Physical examination revealed ascites, tachycardia pretibial edema. Transthoracic echocardiography (TTE) hypoechoic, less-mobile mass almost completely filled atrium. Moreover, 18F-fluorodeoxyglucose...

10.3390/medicina61020170 article EN cc-by Medicina 2025-01-21

Management of melanoma has changed significantly with the discovery targeted therapies and immune checkpoint inhibitors (ICI). Our aim in study is to determine which treatment alternatives, specifically dabrafenib plus trametinib ICIs, are effective adjuvant therapy as first-line metastatic therapy. This retrospective, multicenter included 120 patients diagnosed stage IIIB-IIID receiving both between 2007 2023. Data on clinicopathologic characteristics, regimens outcomes were collected....

10.1038/s41598-025-87553-z article EN cc-by-nc-nd Scientific Reports 2025-01-25

Background: Extrapulmonary neuroendocrine carcinomas (EP-NECs) are rare, aggressive malignancies with no standardized treatment approach. Although platinum-based chemotherapy is considered the first-line therapy, overall survival (OS) and progression-free (PFS) remain limited. This study aims to evaluate clinical pathological characteristics of EP-NEC patients, their responses, outcomes. Methods: retrospective observational included 29 patients diagnosed followed between 2015 2024. Clinical...

10.20944/preprints202503.0015.v1 preprint EN 2025-03-03

Amaç: Hepatoselüler karsinom (HCC), dünya genelinde önemli bir sağlık sorunu olan karaciğer kanseridir. Çoğu hasta unrezektabl evrede tanı alır. Lokorejyonel tedaviler (LRT) ve sorafenib gibi sistemik tedaviler, HCC tedavisinde kullanılan yöntemlerdir. Bu çalışmada, LRT kombinasyonunun hastalarındaki etkinliği güvenilirliği retrospektif olarak araştırılmıştır. Gereç Yöntem: 2018-2023 yılları arasında İstanbul Medipol Üniversitesi Hastanesi'nde takip edilen 20 hastası çalışmaya dahil edildi....

10.19161/etd.1569835 article TR Ege Tıp Dergisi 2025-03-12

Background/Objectives: Extrapulmonary neuroendocrine carcinomas (EP-NECs) are rare, aggressive malignancies with no standardized treatment approach. Although platinum-based chemotherapy is considered the first-line therapy, overall survival (OS) and progression-free (PFS) remain limited. This study aims to evaluate clinical pathological characteristics of EP-NEC patients, their responses, outcomes. Methods: retrospective observational included 29 patients diagnosed followed between 2015...

10.3390/jcm14072264 article EN Journal of Clinical Medicine 2025-03-26

Amaç: Çalışmamızda, torasik bölgeye radyoterapi (TRT)/ kemoradyoterapi (KRT) +/- immünoterapi (İO) alan hastalarda gelişen radyasyon pnömoniti sürecini ve etki eden faktörlerin ortaya konulması amaçlanmıştır. Yöntem: TRT hastaların verileri retrospektif olarak tarandı 26 hastanın analiz edildi. Bulgular: Hastaların ortanca yaşı 54.5 iken çoğu erkekti. çoğunluğunda primer tanı akciğer kanseri idi. Ondört hasta (%53.8) eş zamalı KRT alırken, 13 (%50) IO ile zamanlı RT almıştı. Toplamda ise 17...

10.33713/egetbd.1527615 article TR Ege Tıp Bilimleri Dergisi 2024-10-11
Coming Soon ...